UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037267
Receipt No. R000042489
Scientific Title A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.
Date of disclosure of the study information 2019/07/12
Last modified on 2020/10/09 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.
Acronym A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.
Scientific Title A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.
Scientific Title:Acronym A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To confirm effects caused by test food whole body endurance and fatigue feeling after exercise.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes *Maximum oxygen uptake
*Visual analog scale questionnaire on fatigue feeling
Key secondary outcomes *Rate of perceived exertion
*Exercise performance
*PWC@75%HRmax
*Heart beat number on exercise
*Blood biochemical parameters
*IL-6
*Growth hormone
*Glucagon
*Free fatty acid
*Microbiota of gut
*Blood metabolome analysis
*Muscle mass
*Body fat mass
*SF-8 questionnaire
*Incidence rate of adverse events and side effects

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intake four tablets of test food per one day for nine weeks.
Interventions/Control_2 Intake four tablets of test food per one day for nine weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
49 years-old >=
Gender Male
Key inclusion criteria 1)Males aged 20-49 years at a time of obtaining informed consent.
2)Subjects who have exercise habits (over 30 minutes at once) once or twice a week.
3)Subjects who can continue with the exercise habits.
4)Subjects who don't take prohibited foods whthin one week before informed consent and can keep it during test period.
5)Subjects who show understanding of the clinical study procedures and agreement with participating this study by written informed consent.
Key exclusion criteria 1) Smokers except subjects who has not been smoking more than one year.
2) From the background questionnaire at preliminary test, subjects who defecate less than and equal to 5 times in a week, who have weakness in their digestive organ, and/or who easily have diarrhea.
3) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ).
4) Subjects who have excessive alcohol intake.
5) Subjects who have extremely irregular dietary habits, have midnight work or irregular shift work.
6) Subjects who have allergy to medicines or foods.
7) Subjects who are participating the other clinical test, were participating it within the past 4 weeks, or are going to participate it.
8) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study.
9) Subjects who donated over 400mL blood and/or blood components within the last three month to the current study.
10) Subjects who are going to be collected over 1200mL blood and/or blood components which is collected whithin the last 12 month and at this study
11) Subjects judged as unsuitable for the study by the principal or attending investigator.
Target sample size 90

Research contact person
Name of lead principal investigator
1st name Suguru
Middle name
Last name Fujiwara
Organization CPCC Company Limited
Division name Division of Clinical Research
Zip code 101-0047
Address 4F Sanwauchikannda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN
TEL 03-5297-3112
Email cpcc-contact@cpcc.co.jp

Public contact
Name of contact person
1st name Masanori
Middle name
Last name Numa
Organization CPCC Company Limited
Division name Planning & Sales Department
Zip code 101-0047
Address 4F Sanwauchikanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN
TEL 03-5297-3112
Homepage URL
Email cpcc-contact@cpcc.co.jp

Sponsor
Institute CPCC Company Limited
Institute
Department

Funding Source
Organization ASAHI QUALITY & INNOVATIONS, LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Chiyoda Paramedical Care Clinic
Address 2F Sanwauchikannda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan
Tel 03-5297-5548
Email IRB@cpcc.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 90
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 06 Month 24 Day
Date of IRB
2019 Year 06 Month 21 Day
Anticipated trial start date
2019 Year 07 Month 12 Day
Last follow-up date
2019 Year 12 Month 22 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 07 Month 04 Day
Last modified on
2020 Year 10 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042489